Holen Sie sich die Stockscreener-App
6.74
5.62%
0.33
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
Will Alpha Tau Medical Ltd. stock deliver better than expected guidanceJuly 2025 Breakouts & Free Safe Entry Trade Signal Reports - ulpravda.ru
Is Alpha Tau Medical Ltd. Equity Warrant stock supported by strong cash flowsMarket Sentiment Summary & Reliable Momentum Entry Alerts - ulpravda.ru
Will Alpha Tau Medical Ltd. stock deliver strong dividend growthJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - ulpravda.ru
Will Alpha Tau Medical Ltd. Equity Warrant stock sustain high P E ratiosQuarterly Portfolio Report & High Win Rate Trade Tips - ulpravda.ru
Will Alpha Tau Medical Ltd. stock benefit from infrastructure spendingQuarterly Risk Review & Technical Analysis for Trade Confirmation - ulpravda.ru
Why Alpha Tau Medical Ltd. stock remains a top recommendation2025 Year in Review & Free Weekly Watchlist of Top Performers - ulpravda.ru
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026 - TipRanks
Alpha Tau reports new positive results in two upcoming presentations - MarketScreener
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study - Yahoo Finance
Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating - Investing.com
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical - TipRanks
Throwing Precision Darts: The Company Leading Next Evolution of Cancer Radiation - The Globe and Mail
Bond Watch: Is Alpha Tau Medical Ltd stock a buy before product launchesJuly 2025 Gainers & Long-Term Capital Growth Strategies - moha.gov.vn
Alpha Tau submits first pre-market approval module to the FDA - MarketScreener
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy - TipRanks
Alpha Tau submits PMA module to FDA for Alpha DaRT - TipRanks
New radiation implant edges closer for tough-to-treat skin cancer patients - Stock Titan
What drives Alpha Tau Medical Ltd stock priceSwing Trading Watchlist & High Return Capital Gains - earlytimes.in
Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Graphite India Limited At Decision Level — Rebound or ResistanceSupport Zone Identification & Double Digit Profit Strategies - bollywoodhelpline.com
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 58.8% in December - MarketBeat
Pharma News: Can Alpha Tau Medical Ltd Equity Warrant stock hit record highs again2025 Market Outlook & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
How supply chain issues affect Alpha Tau Medical Ltd. stock2025 Market Overview & AI Driven Price Predictions - Улправда
Alpha Tau announces two Alpha DaRT abstracts at ASCO Symposium - MSN
Will Alpha Tau Medical Ltd. stock attract more institutional investorsPortfolio Performance Report & Accurate Trade Setup Notifications - Улправда
Entry Recap: How supply chain issues affect Alpha Tau Medical Ltd. stockJuly 2025 Earnings & Weekly High Potential Alerts - Улправда
Will Alpha Tau Medical Ltd. stock deliver shareholder valueQuarterly Profit Review & Verified Short-Term Plans - Улправда
Earnings Miss: How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stock2025 Sector Review & Smart Swing Trading Alerts - Улправда
Market Recap: What insider trading reveals about Alpha Tau Medical Ltd. stockJuly 2025 Drop Watch & Risk Managed Investment Signals - Улправда
Alpha Tau Medical’s innovative cancer treatment study update: A potential game-changer - MSN
Is Alpha Tau Medical Ltd. stock a buy before product launches2025 AllTime Highs & Fast Gain Swing Alerts - Bölüm Sonu Canavarı
Will Alpha Tau Medical Ltd. Equity Warrant stock outperform Nasdaq index2025 Volume Leaders & AI Powered Market Trend Analysis - Улправда
Why Alpha Tau Medical Ltd. stock is seen as undervaluedTrade Volume Report & Stock Timing and Entry Methods - Улправда
Will Alpha Tau Medical Ltd. stock attract ESG investorsWeekly Stock Report & Daily Volume Surge Signals - Улправда
How Alpha Tau Medical Ltd. Equity Warrant stock performs during Fed tightening cyclesWeekly Profit Recap & Long-Term Growth Portfolio Plans - DonanımHaber
Aug Levels: Will Alpha Tau Medical Ltd. stock attract more institutional investorsJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Is Alpha Tau Medical Ltd. stock positioned for long term growthJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда
Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings seasonJuly 2025 News Drivers & Weekly Sector Rotation Insights - Улправда
Is Alpha Tau Medical Ltd. stock positioned well for digital economyBond Market & Breakout Confirmation Alerts - Улправда
Buyout Rumor: Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings season2025 Technical Overview & Free Real-Time Market Sentiment Alerts - Улправда
Will Alpha Tau Medical Ltd. stock outperform tech sector in 2025Market Risk Summary & Accurate Intraday Trade Tips - Улправда
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch - TipRanks
Alpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference - TipRanks
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference - The Manila Times
Alpha Tau Medical (NASDAQ: DRTS) to present at J.P. Morgan 2026 event - Stock Titan
Risk Report: Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings season2025 Market Outlook & Consistent Profit Trade Alerts - Улправда
How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stockJuly 2025 Final Week & Precise Buy Zone Identification - Улправда
What insider trading reveals about Alpha Tau Medical Ltd. stockWeekly Risk Report & Weekly Stock Breakout Alerts - Улправда
1.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):